We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Citizens Financial Group
CFG
$30.6B
| $88K | ﹤0.01% |
+2,012
| New | +$89K |
|
527
Ryan Specialty Holdings
RYAN
$10.9B
| $88K | ﹤0.01% |
1,373
| – | – |
|
528
Eaton
ETN
$174B
| $87K | ﹤0.01% |
263
+8
| +3% | +$2.81K |
|
529
Intuit
INTU
$91.3B
| $87K | ﹤0.01% |
138
+2
| +1% | +$1.28K |
|
530
Mondelez International
MDLZ
$78.1B
| $86K | ﹤0.01% |
1,439
-290
| -17% | -$19.2K |
|
|
WCN
531
Waste Connections
WCN
$41.8B
| $86K | ﹤0.01% |
503
| – | – |
|
532
Dow Inc
DOW
$21.9B
| $85K | ﹤0.01% |
2,123
+1,106
| +109% | +$51.6K |
|
533
Marriott International
MAR
$90.6B
| $83K | ﹤0.01% |
+296
| New | +$81.3K |
|
534
HubSpot
HUBS
$10.8B
| $82K | ﹤0.01% |
+117
| New | +$75.2K |
|
535
Iron Mountain
IRM
$36.2B
| $82K | ﹤0.01% |
776
-96
| -11% | -$11.3K |
|
536
Lennar Class A
LEN
$20.6B
| $82K | ﹤0.01% |
+622
| New | +$101K |
|
537
Advanced Micro Devices
AMD
$776B
| $81K | ﹤0.01% |
672
-14
| -2% | -$2.01K |
|
538
indie Semiconductor
INDI
$801M
| $81K | ﹤0.01% |
19,945
| – | – |
|
539
PNC Financial Services
PNC
$100B
| $81K | ﹤0.01% |
420
-204
| -33% | -$40.1K |
|
540
American Express
AXP
$228B
| $79K | ﹤0.01% |
+266
| New | +$76.4K |
|
541
Boston Scientific
BSX
$73.5B
| $78K | ﹤0.01% |
869
-90
| -9% | -$7.92K |
|
542
Ross Stores
ROST
$81.5B
| $78K | ﹤0.01% |
+518
| New | +$76.1K |
|
543
US Bancorp
USB
$99.8B
| $78K | ﹤0.01% |
1,641
-782
| -32% | -$38.5K |
|
544
CoStar Group
CSGP
$12.6B
| $77K | ﹤0.01% |
1,082
| – | – |
|
545
Marvell Technology
MRVL
$191B
| $77K | ﹤0.01% |
696
| – | – |
|
546
Raymond James Financial
RJF
$34.5B
| $77K | ﹤0.01% |
495
| – | – |
|
547
SLB Ltd
SLB
$78.8B
| $76K | ﹤0.01% |
1,993
+643
| +48% | +$27K |
|
548
Robinhood
HOOD
$85B
| $75K | ﹤0.01% |
+2,019
| New | +$65.2K |
|
549
Occidental Petroleum
OXY
$58.5B
| $75K | ﹤0.01% |
+1,509
| New | +$76.2K |
|
550
Sempra
SRE
$55.2B
| $75K | ﹤0.01% |
851
-203
| -19% | -$17.8K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.